The Latest Cardiac and Vascular News
Grenoble, France, June 30, 2021 — Electroducer, the designer and developer of the innovative medical device Electroducer Sleeve® which treats heart valve disease, today announces that it has raised €3 million ($3.65M) from private investors and French public stakeholders. The funds will be used for marketing its new technology, which has been […]
Accelerating development of company’s elegant valve replacement solution for mitral and tricuspid applications CAMPBELL, Calif., July 7, 2021 /PRNewswire/ — Tioga Medical, Inc., a Shifamed portfolio company that aims to redefine structural heart valve replacement, announced today the initial closing of its committed $30M Series B financing. Led by The Capital Partnership (TCP), with participation […]
– Anthony DiTonno Retires from Tenax; Christopher Giordano Appointed as CEO – MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company that address cardiovascular and pulmonary diseases with high unmet medical need, today announced a CEO transition in connection with the retirement of its current CEO: Effective July 13, […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will release second quarter 2021 financial results on Wednesday, August 4, 2021. AtriCure will host a conference call at 4:30 p.m. Eastern Time on Wednesday, August […]
SANTA CLARA, Calif. and DUBLIN, July 6, 2021 /PRNewswire/ — Treo Ventures portfolio company CVRx, Inc. announced the upsized pricing of its initial public offering on the Nasdaq Global Select Market. Treo led the pre-IPO round in July 2020 with Treo General Partner, Mudit K. Jain, PhD, joining the CVRx Board. CVRx is a commercial-stage medical technology company […]
CALGARY, Alberta, July 06, 2021 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix”) (TSX:RVX) today announced that Ken Lebioda is stepping down as Senior Vice President, Business and Corporate Development, effective immediately. “We would like to thank Ken for his important contributions over many years of service and wish him all the […]
Deal adds second FDA 510(k) cleared device to thrombectomy platform Easy-to-use, stand-alone, single session mechanical thrombectomy for removal of venous clot in highly attractive, rapidly growing and significantly under-penetrated market FDA 510(k) cleared (Dec. 2020) and CE Mark Certification (May 2021) 12-month follow-up data of 19-patient feasibility trial presented at […]
Monday, 6 July 20201. Vasorum Limited has announced the appointment of Bob Smouse M.D., F.A.C.R., as a non-executive director. Vasorum is a Dublin based, high-growth medical device business specializing in sophisticated devices used to close arterial punctures in vascular, cardiology, radiology, and neuro-radiology procedures. In February of this […]
Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced pricing of its previously announced […]
SOUTH SAN FRANCISCO, Calif., July 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 30, 2021 it granted stock options to purchase an aggregate of 90,000 shares of common stock to twelve new employees whose employment commenced in June 2021 as a material inducement to […]
